SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 56 filers reported holding SAVARA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,920 | +18.3% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $44,730 | +63.8% | 14,000 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $27,300 | +25.8% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $21,700 | +98536.4% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22 | +4.8% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21 | +16.7% | 14,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $18 | +5.9% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $17 | -10.5% | 14,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $19 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |